HMG20B 抗体 (AA 1-100) (AbBy Fluor® 680)
Quick Overview for HMG20B 抗体 (AA 1-100) (AbBy Fluor® 680) (ABIN4997588)
抗原
See all HMG20B 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-100
-
交叉反应
- 小鼠
-
预测反应
- Human,Rat,Cow
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human BRAF35
-
亚型
- IgG
-
-
anti-High Mobility Group 20B (HMG20B) (AA 1-109) antibody
HMG20B 适用: 人 WB, ELISA, IF, IHC (p) 宿主: 小鼠 Monoclonal 1F6 unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-317) antibodyHMG20B 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) antibodyHMG20B 适用: 人 WB, IF, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B 适用: 人 WB, IHC, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-317) antibodyHMG20B 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B 适用: 人 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 27-213) antibodyHMG20B 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-213) antibodyHMG20B 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (N-Term) antibodyHMG20B 适用: 人 WB, IHC, IF, IC 宿主: 兔 Polyclonal unconjugated
anti-High Mobility Group 20B (HMG20B) (AA 1-100) antibodyHMG20B 适用: 小鼠 WB, ELISA, IF (cc), IF (p), ICC, IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
别名
- BRAF35
-
背景
-
Synonyms: BRAF25, BRAF35, BRCA 2 Associated Factor 35 kDa, BRCA2 associated factor 35, BRCA2-associated factor 35, High Mobility Group Protein 20B, HM20B_HUMAN, HMG 20B, HMG box containing protein 20B, HMG box-containing protein 20B, HMG domain-containing protein 2, HMG domain-containing protein HMGX2, hmg20b, HMGX2, PP7706, pp8857, SMARCE1 related protein, SMARCE1-related protein, SMARCE1r, sox like, Sox like transcriptional factor, Sox-like transcriptional factor, SOXL, Structural DNA binding protein BRAF35, Structural DNA-binding protein BRAF35, SWI/SNF related, SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily E member 1 related, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related.
Background: The breast cancer susceptibility gene (BRCA1) localizes to chromosome 17q. Mutations within this gene account for approximately 45 % of families with high incidence of breast cancer and at least 80 % of families with increased incidence of both early-onset breast cancer and ovarian cancer. A second breast cancer susceptibility gene, BRCA2, located on chromosome 13q12-13, also confers a high incidence of breast cancer, but unlike BRCA1, BRCA2 does not confer a substantially elevated risk of ovarian cancer. The BRCA2-Associated Factor 35 (BRAF35) protein forms a complex with BRCA2, which associates with condensed chromatin during histone H3 phosphorylation. BRAF35 expression levels are highest in proliferating tissues and parallel BRCA2 expression patterns. The structure of BRAF35 includes a kinesin-like coiled coil domain and a nonspecific DNA binding HMG domain. The chromatin localization of BRAF35 and antibody microinjection studies indicate a role for the BRAF35/BRCA2 complex in cell cycle regulation.
-
基因ID
- 10362
抗原
-
